|
| Study | Sample size (treatment/control) | Diagnosis standard | Complications | Intervention | Control | Treatment course (month) | Clinical standards | Outcome measure |
|
| Cheng 2007 [14] | 99 (53/46) | Diagnostic criteria for PAF (unclear) | PAF | WXKL 9 g tid + control | Enteric-coated aspirin | 3 | Clinical guideline of new drugs for TCM (1995) | Pd |
|
| Jin 2011 [15] | 60 (30/30) | Diagnostic criteria for PAF (unclear) | PAF | WXKL 9 g tid | Conventional therapy (no detailed information) | 6 | Unclear | Pd |
|
| Zhang et al. 2008 [16] | 141 (72/69) | Diagnostic criteria for PAF (unclear)
CGMH (2005) | Elderly hypertension and PAF | WXKL 9 g qd | Amiodarone | 2 | 24 h Holter | Pd, ADR |
|
| Lv et al. 2010 [17] | 120 (60/60) | Diagnostic criteria for PAF (unclear) | Elderly PAF | WXKL 9 g tid + control | Amiodarone | 12 | Clinical guideline of new drugs for TCM (1995) | Pd, ADR |
|
| Dong et al. 2010 [18] | 86 (42/40) | ESC-NASPE (2003)
CGMH (2005) | Hypertension and PAF | WXKL 9 g tid + fluvastatin | Conventional therapy (no detailed information) | 12 | Unclear | Pd, ADR |
|
| Yan et al. 2011 [19] | 80 (40/40) | Diagnostic criteria for PAF (unclear) | PAF | WXKL 5 g qd + control | Amiodarone | 12 | Unclear | Pd,
maintenance rate of sinus rhythm |
|
| Zhang 2012 [20] | 76 (38/38) | Diagnostic criteria for PAF (unclear) | PAF | WXKL 5 g tid + control | Amiodarone | 6 | National integrative arrhythmia prevention research symposium revised standard | Pd |
|
| Lu et al. 2010 [21] | 68 (34/34) | ESC-NASPE (2003)
CGMH (2005) | Elderly hypertension and PAF | WXKL 9 g tid + fluvastatin | Conventional therapy (no detailed information) | 6 | Unclear | Pd,
maintenance rate of sinus rhythm, ADR |
|
| Zhang et al. 2011 [22] | 115 (59/56) | Diagnostic criteria for PAF (unclear) | Elderly DHF and PAF | WXKL 9 g tid | Conventional therapy (no detailed information) | 3 | Antiarrhythmic drug therapy recommendations (2001) | Pd |
|
| Xie and Shen 2006 [23] | 26 (12/14) | Diagnostic criteria for PAF (unclear) | PAF | WXKL 9 g tid + irbesartan | Amiodarone | 6 | Unclear | Maintenance rate of sinus rhythm, ADR |
|
| Xu 2008 [24] | 87 (44/43) | Diagnostic criteria for PAF (unclear) | PAF | WXKL 9 g tid + valsartan | Amiodarone | 24 | Unclear | Maintenance rate of sinus rhythm |
|
| Gao 2012 [25] | 60 (30/30) | Diagnostic criteria for PAF (unclear) | Hypertension and PAF | WXKL 9 g tid + control | Valsartan | 12 | Unclear | Maintenance rate of sinus rhythm |
|
| Li et al. 2008 [26] | 62 (32/30) | Diagnostic criteria for PAF (unclear) | PAF | WXKL 9 g tid + control | Amiodarone | 6 | Unclear | Maintenance rate of sinus rhythm, ADR |
|
| Zheng and Zhang 2013 [27] | 100 (50/50) | ACC/AHA/ESC (2006) | PAF | WXKL 9 g tid + control | Amiodarone | 9 | Unclear | Maintenance rate of sinus rhythm, ADR |
|
